Rekvina Labs Ltd PE Ratio

Rekvina Labs PE Ratio

Image

Rekvina Labs Ltd

NSE: REKVINALABS

PE

-

Last updated on: Sep 07, 2026

Key Highlights

  • The P/E Ratio of Rekvina Labs Ltd is 0 as of 07 Sep 15:30 PM The P/E Ratio of Rekvina Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years .

Historical P/E Ratio of Rekvina Labs Ltd

No data available

Company Fundamentals for Rekvina Labs Ltd

Image

Rekvina Labs Ltd

NSE: REKVINALABS

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Rekvina Labs Ltd

1M

1Y

3Y

5Y

Monitoring Rekvina Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Sep 202654.9
04 Sep 202653.83
03 Sep 202652.78
02 Sep 202651.75
01 Sep 202650.74
31 Aug 202649.75
28 Aug 202648.78
27 Aug 202647.83
26 Aug 202646.9
25 Aug 202645.99

BlinkX Score for Rekvina Labs Ltd

Asset Value vs Market Value of Rekvina Labs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Rekvina Labs Ltd59.84
Sun Pharmaceutical Industries Ltd455634
Divis Laboratories Ltd241576
Torrent Pharmaceuticals Ltd184478
Cipla Ltd111888
Zydus Lifesciences Ltd111820

Key Valuation Metric of Rekvina Labs Ltd

X

Historical Market Cap of Rekvina Labs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Rekvina Labs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Rekvina Labs Ltd

No data available

* All values are in %

About Rekvina Labs Ltd

  • Rekvina Labs Limited was incorporated on 1st November 1988.
  • From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore.
  • It is registered in England and Wales as a Public Limited Company.
  • The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements.
  • It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products.

Rekvina Labs Ltd News Hub

Rekvina Labs revises AGM Date

Rekvina Labs has revised the Annual General Meeting (AGM) of the company which was scheduled to held

Read more

10 Aug 24

Rekvina Labs to conduct board meeting

Rekvina Labs will hold a meeting of the Board of Directors of the Company on 30 August 2024. Powered

Read more

26 Aug 24

Rekvina Labs revises board meeting date

Rekvina Labs has revised the meeting of the Board of Directors which was scheduled to be held on 30

Read more

31 Aug 24

Rekvina Labs AGM scheduled

Rekvina Labs announced that the Annual General Meeting (AGM) of the company will be held on 27 Septe

Read more

04 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions